_neoadjuvant-talazoparib-active-in-brca-mutated-early-breast-cancer-124-jennifer-litton-preview-1.jpg "Neoadjuvant talazoparib active in BRCA-mutated early breast cancer | Jennifer Litton from talazorqiy Video Screenshot Preview 1")
Gallery_neoadjuvant-talazoparib-active-in-brca-mutated-early-breast-cancer-124-jennifer-litton-preview-3.jpg "Neoadjuvant talazoparib active in BRCA-mutated early breast cancer | Jennifer Litton from talazorqiy Video Screenshot Preview 3")
Gallery_neoadjuvant-talazoparib-active-in-brca-mutated-early-breast-cancer-124-jennifer-litton-preview-hqdefault.jpg "Neoadjuvant talazoparib active in BRCA-mutated early breast cancer | Jennifer Litton from talazorqiy Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 4 minutes 56 seconds
👁 View: 52 times
Play Audio:👁 View: 52 times
Description:
Medicine Matters oncology
Medicine Matters oncology
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_talave-induction-talazoparib-with-parp-inhibition-in-breast-cancer.webp "VJOncology")
_talazoparib-in-locally-advanced-or-metastatic-breast-cancer.webp "VJOncology")
_implications-of-the-fda-approval-of-combination-talazoparib-amp-enzalutamide-therapy.webp "Grand Rounds in Urology")
⏲ 9 minutes 29 seconds 👁 226
_talazoparib-plus-enzalutamide-shows-improvement-in-pfs-over-soc-in-first-line-hrr-mcrpc.webp "ecancer")
⏲ 5 minutes 1 second 👁 128
_neoadjuvant-talazoparib-active-in-brca-mutated-early-breast-cancer-124-jennifer-litton.webp "Medicine Matters oncology")
⏲ 4 minutes 56 seconds 👁 52
_dr-yardley-discusses-data-with-talazoparib-in-breast-cancer.webp "OncLiveTV")
_talapro-2-study-of-talazoparib-enzalutamide-in-prostate-cancer-stephen-freedland-and-neeraj-agarwal.webp "Oncology Data Advisor")
TALAPRO-2 Study of Talazoparib Enzalutamide in Prostate Cancer: Stephen Freedland and Neeraj Agarwal
⏲ 18 minutes 58 seconds 👁 139
_dr-agarwal-on-the-safety-profile-of-enzalutamide-talazoparib-in-mcrpc.webp "OncLiveTV")
_talave-induction-talazoparib-with-parp-inhibition-in-breast-cancer.jpg)
_talazoparib-in-locally-advanced-or-metastatic-breast-cancer.jpg)
_implications-of-the-fda-approval-of-combination-talazoparib-amp-enzalutamide-therapy.jpg)
_talazoparib-plus-enzalutamide-shows-improvement-in-pfs-over-soc-in-first-line-hrr-mcrpc.jpg)
_neoadjuvant-talazoparib-active-in-brca-mutated-early-breast-cancer-124-jennifer-litton.jpg)
_dr-yardley-discusses-data-with-talazoparib-in-breast-cancer.jpg)
_talapro-2-study-of-talazoparib-enzalutamide-in-prostate-cancer-stephen-freedland-and-neeraj-agarwal.jpg)
_dr-agarwal-on-the-safety-profile-of-enzalutamide-talazoparib-in-mcrpc.jpg)
![[+]](/images/menu.gif){kind=small}